February 19, 2022 – AcroImmune BioTech Co., Ltd. (Guangzhou) (AcroImmune) announced that its co-founder and board member, Dr. Pan Zheng, has been elected to the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE) for the class of 2022. This prestigious recognition honors Dr. Zheng's outstanding contributions to the development of immune checkpoint modulators in cancer immunotherapy and COVID-19 treatments.
